Now a proud SmiLe Alumni member! https://www.linkedin.com/feed/update/urn:li:activity:6495303115359817728

Emmace will have a strong presence during the upcoming DDL2018 conference. Please drop by and have a chat with our advisors and specialists. Emmace Consulting is a Bronze Sponsor (booth 314) at Drug Delivery to the Lungs 2018 in Edinburgh 12th-14th December.

Per Bäckman, Senior Inhalation Consultant, now in our team. #amazingstaff ;-) Read more about Emmace Team

Emmace Consulting is attending RDD 2018 in Arizona as a technology exhibitor. Both Bo Olsson and Mårten Svensson will be happy to discuss how Emmace Consulting can help you develop inhaled products. Two posters are also presented. Please drop by and have a chat with us. Bo Olsson is also presenting the Mimetikos Preludium on the podium (Session 6). Don't miss the opportunity to book a personal F2F demonstration of the unique software. Read more about the capabilities of Emmace Consulting and Mimetikos Preludium™ Software.

During the upcoming DDL2017 conference, Dr. Bo Olsson, Senior Advisor at Emmace Consulting, will be happy to demonstrate the Mimetikos Preludium application for anyone interested. Book a F2F meeting with Bo by contacting him at bo@emmace.se. Emmace Consulting is a Bronze Sponsor at Drug Delivery to the Lungs 2017 in Edinburgh 6th-8th December. Come and visit us at booth 314 in The Lennox Suite. Mimetikos Preludium™ software is a modeling package for estimating regional deposition of inhaled aerosols in man. The package is particularly focused on pharmaceutical aerosols but is equally applicable to environmental aerosols. Read more about Mimetikos Preludium™ Software

Emmace Consulting has, in collaboration with S5 Consulting and Jolyon Mitchell Inhaler Consulting Services Inc, jointly published an analytical test approach that is more in-vivo like than the existing pharmacopeia methods. Don’t hesitate to contact the authors for more information.

In May 2017, the University of Cyprus (Cyprus), Mylan Pharma UK Ltd (UK), and Emmace Consulting AB entered into a joint research agreement with the aim of developing a state-of-the-art scientific methodology to study upper airway deposition of inhaled medicines. The collaboration will effectively combine the key competencies of the computational Sciences Laboratory at UCY (UCy-CompSci) and their High Performance Computing (HPC) system, the skilled aerosol characterization laboratories at Emmace Consulting AB and the respiratory product development expertise of Mylan Pharma UK Ltd. This collaboration also marks an important milestone for the European Union COST Action MP1404 - “SimInhale” which is coordinated by UCY-CompSci. First results are planned to be reported in the scientific literature in early 2018.